Biblio
Found 16 results
Sort by: Author Title Type [ Year
] Filters: Author is Barkhof, F [Clear All Filters]
. 2010 revisions to McDonald criteria for diagnosis of multiple sclerosis: impact of 3-Tesla magnetic resonance imaging. Ann Neurol [Internet]. 2011;70:182-183. Available from: http://www.hubmed.org/display.cgi?uids=21710623
. Cardiovascular and interventional radiological society of europe commentary on the treatment of chronic cerebrospinal venous insufficiency. Cardiovasc Intervent Radiol [Internet]. 2011;34:1-2. Available from: http://www.hubmed.org/display.cgi?uids=21136256
. The changing face of multiple sclerosis clinical trial populations. Curr Med Res Opin [Internet]. 2011;27:1529-1537. Available from: http://www.hubmed.org/display.cgi?uids=21671851
Efficacy of vitamin D(3) as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial. J Neurol Sci [Internet]. 2011;311:44-49. Available from: http://www.hubmed.org/display.cgi?uids=21620416
Functional adaptive changes within the hippocampal memory system of patients with multiple sclerosis. Hum Brain Mapp [Internet]. 2011. Available from: http://www.hubmed.org/display.cgi?uids=21898674
. Functional connectivity changes in multiple sclerosis patients: A graph analytical study of MEG resting state data. Hum Brain Mapp [Internet]. 2011. Available from: http://www.hubmed.org/display.cgi?uids=21954106
. Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis. Mult Scler [Internet]. 2011;17:1202-1210. Available from: http://www.hubmed.org/display.cgi?uids=21561955
. Modeling MR Imaging Enhancing-Lesion Volumes in Multiple Sclerosis: Application in Clinical Trials. AJNR Am J Neuroradiol [Internet]. 2011. Available from: http://www.hubmed.org/display.cgi?uids=22051810
MRI assessment of iron deposition in multiple sclerosis. J Magn Reson Imaging [Internet]. 2011;34:13-21. Available from: http://www.hubmed.org/display.cgi?uids=21698703
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. Lancet [Internet]. 2011;378:1779-1787. Available from: http://www.hubmed.org/display.cgi?uids=22047971
One year activity on subtraction MRI predicts subsequent 4 year activity and progression in multiple sclerosis. J Neurol Neurosurg Psychiatry [Internet]. 2011;82:1125-1131. Available from: http://www.hubmed.org/display.cgi?uids=21429902
Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. Eur Radiol [Internet]. 2010;20:1675-1683. Available from: http://www.hubmed.org/display.cgi?uids=20094887
Long-interval T2-weighted subtraction magnetic resonance imaging: a powerful new outcome measure in multiple sclerosis trials. Ann Neurol [Internet]. 2010;67:667-675. Available from: http://www.hubmed.org/display.cgi?uids=20437564
. Performance of the Swanton multiple sclerosis criteria for dissemination in space. Mult Scler [Internet]. 2010. Available from: http://www.hubmed.org/display.cgi?uids=20547588
Short-term adaptation to a simple motor task: a physiological process preserved in multiple sclerosis. Neuroimage [Internet]. 2009;45:500-511. Available from: http://www.hubmed.org/display.cgi?uids=19135155
. Glucocorticoid receptor gene polymorphisms associated with more aggressive disease phenotype in MS. J Neuroimmunol [Internet]. 2007;186:150-155. Available from: http://www.hubmed.org/display.cgi?uids=17395275
